目的研究供体骨髓细胞输注减轻大鼠肺移植急性排斥反应。
Objective To study donor bone marrow infusion relieving acute rejection of rat lung allograft.
结论：同供体肾移植及骨髓细胞输注是一种可行的诱导免疫耐受的方法，且简便安全。
Conclusion: Donor bone marrow transfusion was safe and beneficial. It could induce specific immunologic tolerance in the renal allograft recipients.
目的研究供体凋亡细胞预输注对大鼠胰岛移植后胰岛移植物功能的影响。
Objective to observe the influence of transfusion of donor apoptotic cells on the function of islet grafts in rat islet transplantation.
目的：探讨供体特异输注(DST)对同种异体小鼠心脏移植生存期的影响。
Objective: the article was to investigate the effect of donor specific transfusion (DST) on the survival of homologous cardiac transplantation in mice.
目的研究供体凋亡细胞预输注对大鼠胰岛移植后胰岛移植物功能的影响。
To investigate the impacts of cold ischemia preservation time and histocompatibility on the activity of islet cells during the islet transplantation.
方法在“细胞后环磷酰胺”方法的基础上输注供体脾细胞或去除了T细胞的供体脾细胞，然后进行皮肤移植。观察皮肤存活情况并探讨耐受形成机制。
Methods The donor spleen cells (SPC) or T cell depleted donor SPC were injected into the recipients which had been treated by"cells followed by CP system", after which skin grafting was performed.
非去髓性异基因干细胞移植(nst)患者通常在移植后每月输注1次，连续1 ~4次。
Post non myeloablative allogeneic stem cell transplantation (NST) patients usually received DLI one times a month, consecutively 1 ~ 4 times.
探讨了护理因素对异基因造血干细胞移植中abo血型主要不合和次要不合的干细胞输注的影响。
The nursing factors are detected which infect allogeneic peripheral blood haematopoietic stem cell infusion in ABO-major incompatible transplantation or ABO-minor incompatible transplantation.
脐血移植在临床上的应用，主要依赖于对脐血造血细胞的基础研究工作，包括脐血的生物学活性、采集、保存和输注等。
The clinical application of cord blood transplantation mainly depends on base study of hematopoietic cell, including biological activity, collection, retention and infusion of cord blood, and so on.
结论：供体骨髓输注可形成供受体细胞的嵌合状态，可降低同种异体肝移植的排斥反应，延长受体生存时间。
CONCLUSION: Donor specific bone marrow infusion enhances chimerism formation in bone marrow, alleviates the rejection of liver allotransplantation and improve survival of liver allotransplantation.
目的探讨输注同种脾细胞建立小鼠输血相关的移植物抗宿主(TA -GVHD)模型及其特点。
Objective To develop transfusion associated graft vs host disease (TA-GVHD) model by infusing allogeneic splenocytes.
结论：次要血型不合及输注细胞数多的患者红系恢复较快，而年龄大和非血缘骨髓移植的患者红系恢复慢。
In conclusion, the erythrocyte recovery is more quick in patients with minor ABO incompatible and more number of mononuclear cells infused, while it is slow in patents with old age and unrelated BMT.
白血病患者和进行外周血或骨髓造血干细胞移植的患者，由于自身缺乏巨细胞病毒抗体，给他们输注的成分血必须是巨细胞病毒抗体阴性的。
Patients with leukemia and those undergoing blood or marrow stem cell transplantation, who themselves have no antibodies to CMV, should receive blood components that are negative for CMV antibodies.
脐带血富含造血祖细胞，既可作为造血干细胞移植新的来源，又可用于骨髓抑制患者的临床输注，有广阔的应用前景。
The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...
结论造血干细胞移植后输注致敏供者的淋巴细胞能促进受者的免疫功能重建，并可减少GVHD的发生。
Conclusion Sensitized donor lymphocytes infusion after HSCT evidently promoted the immune reconstitution and reduced the incidence of GVHD.
方法：采用大鼠异位(颈部)心脏移植模型，通过门静脉途径输注不同类型供者特异性抗原。
Methods: a rat model of cervical heterotopic cardiac transplantation was established and the different donor antigens were infused through the portal vein.
目的：在进行心脏移植手术的同时，经门静脉输注供体脾细胞诱导移植耐受，并探讨其耐受机制。
Objective: to induce cardiac transplantation tolerance in rat by perioperative injection of spleen cells into portal vein, and to study the mechanism concerning transplantation tolerance.
另一种可选疗法是二次移植，就是对患者施以供体淋巴细胞输注（即注入的白细胞为来自原造血干细胞供体的淋巴细胞）。
Many CML patients cannot have an allogeneic stem cell transplant. Doctors are studying the use of a patient's own stem cells in these cases. This is called an autologous stem cell infusion .
随机双盲对照研究早期冠状动脉内移植自体骨髓细胞输注治疗急性心肌梗塞的临床试验†regenerate - ami。
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial †.
结果建立了预处理、干细胞输注及并发症的护理方法，提高了移植效果。
Results Established the nursing protocol from donor nursing, stem cell harvest nursing, fore treatment nursing, stem cell transfusion nursing to complication nursing.
结果建立了预处理、干细胞输注及并发症的护理方法，提高了移植效果。
Results Established the nursing protocol from donor nursing, stem cell harvest nursing, fore treatment nursing, stem cell transfusion nursing to complication nursing.
应用推荐